Canada markets closed

Astellas Pharma Inc (YPH.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
9.37+0.23 (+2.47%)
At close: 09:05PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
Total Revenue
1,603,672,000
1,603,672,000
1,518,619,000
1,296,163,000
1,249,528,000
Cost of Revenue
292,485,000
292,485,000
288,353,000
253,009,000
246,063,000
Gross Profit
1,311,187,000
1,311,187,000
1,230,266,000
1,043,154,000
1,003,465,000
Operating Expenses
Research Development
294,187,000
294,187,000
276,128,000
246,010,000
224,489,000
Selling General and Administrative
740,110,000
740,110,000
630,272,000
548,840,000
504,316,000
Total Operating Expenses
1,292,240,000
1,292,240,000
1,098,709,000
912,191,000
867,892,000
Operating Income or Loss
18,947,000
18,947,000
131,557,000
130,963,000
135,573,000
Interest Expense
12,005,000
12,005,000
8,779,000
4,949,000
2,335,000
Income Before Tax
24,969,000
24,969,000
132,361,000
156,886,000
145,324,000
Income Tax Expense
7,924,000
7,924,000
33,647,000
32,800,000
24,734,000
Income from Continuing Operations
17,045,000
17,045,000
98,714,000
124,086,000
120,590,000
Net Income
17,045,000
17,045,000
98,714,000
124,086,000
120,589,000
Net Income available to common shareholders
17,045,000
17,045,000
98,714,000
124,086,000
120,589,000
Basic EPS
19.03
9.51
54.24
67.08
64.93
Diluted EPS
18.84
9.47
54.09
67.05
64.90
Basic Average Shares
1,804,873
1,793,277
1,820,019
1,849,713
1,857,125
Diluted Average Shares
1,812,450
1,799,660
1,825,061
1,850,602
1,858,193